Viridian Therapeutics Inc
Ownership
Ownership Structure
Who owns Viridian Therapeutics Inc (VRDN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.0% of the shares are freely tradable; institutional investors hold 109.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.66 | 16,604,740 | +8.0 | 06/30/2026 |
| BlackRock Inc | 7.55 | 8,551,488 | +9.2 | 06/30/2026 |
| Bellevue Group AG | 5.94 | 6,731,909 | +0.1 | 06/30/2026 |
| Paradigm Biocapital Advisors LP | 5.93 | 6,723,788 | +113.5 | 06/30/2026 |
| Kynam Capital Management, LP | 5.70 | 6,453,877 | +175.6 | 06/30/2026 |
| State Street Corp | 5.41 | 6,124,976 | +31.1 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 5.07 | 5,748,410 | +79.3 | 06/30/2026 |
| Fairmount Funds Management LLC | 4.49 | 5,090,928 | +30.1 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.04 | 4,576,860 | +9.8 | 06/30/2026 |
| Deep Track Capital, LP | 3.17 | 3,592,740 | +157.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Tripuraneni Radhika | Chief Medical Officer | 40,000 | 1,012,000 $ | Aug 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Tousignant Jennifer | Chief Legal Officer | Sell | 10,000 | 24.50 | 245,000 |
| Aug 19, 2026 | Tousignant Jennifer | Chief Legal Officer | Other | 10,000 | 14.41 | 144,100 |
| Aug 19, 2026 | Tousignant Jennifer | Chief Legal Officer | Sell | 4,212 | 24.50 | 103,194 |
| Aug 14, 2026 | Tripuraneni Radhika | Chief Medical Officer | Other | 40,000 | 13.21 | 528,400 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.